Boditech Med announced that it will establish operations in North America. Boditech's expansion begins with plans to open a new manufacturing site in the Miami, Florida, area. The company is also considering opportunities in other states, along with a partnership in Canada.

Boditech offers highly reliable in-vitro diagnostic solutions that empower clinicians and patients to improve health through quick and reliable tests, available anywhere and anytime. Along with venous blood and plasma testing, Boditech's product line includes technologies that enable accurate, thorough capillary blood tests, based on a small amount of blood from a finger prick. Boditech is currently seeking approvals from the U.S. Food and Drug Administration for several diagnostic solutions in cardiac, cancer, hormone, infectious disease, and other therapeutic areas.

Timelines and precise locations remain in the works. Boditech intends to hire hundreds of Americans to support its efforts. Boditech intends to bring lower-cost, rapid testing that covers many critical areas of medicine, from cardiac health to cancer, to the country.

Boditech also produces COVID-19 antibody and over-the-counter rapid antigen tests.